Horizon Kinetics Asset Management LLC Iovance Biotherapeutics, Inc. Transaction History

Horizon Kinetics Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $505,087 - $729,976	-28,076 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $131,648 - $330,063	-13,461 Reduced 32.41%	28,076 $688,000
Q1 2019 May 15, 2019	BUY	$8.41 - $11.26 $349,326 - $467,706	41,537 New	41,537 $395,000

319

244M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $840M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.